TMEM33 is highly expressed in breast cancer cells and up-regulated in early recurrent breast cancer specimens compared with non-recurrent breast tumors (Sakabe et al., 2015), however, its expression in the majority of cancers has not been well characterized. Here, TMEM33 is linked to breast cancer.